Yu Zi-Kui, Chen Yi-Ning, Aihara Makoto, Mao Wei, Uchida Saiko, Araie Makoto
Department of Ophthalmology, University of Tokyo, Japan.
Mol Vis. 2007 Jun 11;13:833-9.
To investigate the effect of beta-adrenergic receptor antagonists against oxidative stress on purified rat retinal ganglion cells (RGCs), timolol, betaxolol, carteolol and nipradilol were included in the present study.
RGCs were purified using a 2 step panning procedure from postnatal days 6-8 using Wistar rats. After 72 h in culture under normal condition, RGCs were exposed to oxidative stress induced by B27 medium without anti-oxidant. To verify whether this stress is apoptotic or necrotic, Annexin V and propidium iodide were used to detect apoptotic and necrotic cells after 2 h stress. The presence of a proinhibitor for intracellular cathepsin B, and an inhibitor for thiol protease (cathepsin B/H/L, calpain), was also assessed to verify necrotic cell death event in oxidative conditions. Next, RGC cultures under oxidative stress were incubated with timolol, betaxolol, carteolol, and nipradilol added, respectively, for 24 h culture. The RGC viability in each condition normalized to that under normal condition was evaluated as live cell percentage based on total experiments of 8-15.
Two h after oxidative stress, Annexin V and propidium iodide positive cells increased. Increased cell death under oxidative stress was significantly reduced by inhibitors for cathepsin or calpain. These data suggest that increased cell death under the current oxidative stress was due to necrosis. Under oxidative stress for 24 h, RGC viability reduced to 52.5-60.2% as compared with normal. With 10 nM and 100 nM timolol, live cell significantly increased to 69.3% and 75.5%, respectively. Both betaxolol and nipradilol enhanced live RGCs significantly in concentration of 100 nM and 1 microM, with viability of 70.5%, 71.6%, and 70.4%, 74.7%, respectively. While with 10 nM, 100 nM and 1 microM addition of carteolol, there was no significant increase in live RGC percentage which ranged from 53.1-55.0%.
Timolol, betaxolol and nipradilol, but not carteolol, showed neuroprotective effects against oxidative stress induced by B27 without antioxidant on purified rat RGCs at concentrations of 10 nM or higher. Although the neuroprotective mechanism of beta-blockers for oxidative stress is still unknown, this additive effect may deserve future studies.
为研究β-肾上腺素能受体拮抗剂对纯化的大鼠视网膜神经节细胞(RGCs)氧化应激的影响,本研究纳入了噻吗洛尔、倍他洛尔、卡替洛尔和尼普地洛。
使用两步淘选法从出生后6 - 8天的Wistar大鼠中纯化RGCs。在正常条件下培养72小时后,将RGCs暴露于不含抗氧化剂的B27培养基诱导的氧化应激中。为验证这种应激是凋亡还是坏死,在应激2小时后使用膜联蛋白V和碘化丙啶检测凋亡和坏死细胞。还评估了细胞内组织蛋白酶B的前体抑制剂以及硫醇蛋白酶(组织蛋白酶B/H/L、钙蛋白酶)的抑制剂的存在情况,以验证氧化条件下的坏死细胞死亡事件。接下来,将氧化应激下的RGC培养物分别与添加的噻吗洛尔、倍他洛尔、卡替洛尔和尼普地洛一起孵育24小时。根据8 - 15次总实验,将每种条件下的RGC活力相对于正常条件下的活力归一化,以活细胞百分比进行评估。
氧化应激2小时后,膜联蛋白V和碘化丙啶阳性细胞增加。组织蛋白酶或钙蛋白酶抑制剂显著降低了氧化应激下增加的细胞死亡。这些数据表明,当前氧化应激下增加的细胞死亡是由于坏死。在氧化应激24小时后,与正常情况相比,RGC活力降至52.5 - 60.2%。使用10 nM和100 nM的噻吗洛尔时,活细胞分别显著增加至69.3%和75.5%。倍他洛尔和尼普地洛在100 nM和1 microM浓度下均显著提高了活RGCs的数量,活力分别为70.5%、71.6%和70.4%、74.7%。而添加10 nM、100 nM和1 microM的卡替洛尔时,活RGC百分比在53.1 - 55.0%范围内没有显著增加。
噻吗洛尔、倍他洛尔和尼普地洛(而非卡替洛尔)在10 nM或更高浓度下对纯化的大鼠RGCs表现出对由不含抗氧化剂的B27诱导的氧化应激的神经保护作用。尽管β受体阻滞剂对氧化应激的神经保护机制尚不清楚,但这种相加作用可能值得未来研究。